Literature DB >> 8955347

Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressin.

B Chini1, B Mouillac, M N Balestre, S Trumpp-Kallmeyer, J Hoflack, M Hibert, M Andriolo, S Pupier, S Jard, C Barberis.   

Abstract

We investigated the mechanisms that regulate the efficacy of agonists in the arginine-vasopressin (AVP)/oxytocin (OT) receptor system. In this paper, we present evidence that AVP, a full agonist of the vasopressin receptors, acts as a partial agonist on the oxytocin receptor. We also found that AVP becomes a full agonist when two aromatic residues of the oxytocin receptor are replaced by the residues present at equivalent positions in the vasopressin receptor subtypes. Our results indicate that these two residues modulate the response of the oxytocin receptor to the partial agonist AVP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8955347     DOI: 10.1016/s0014-5793(96)01135-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Functional selective oxytocin-derived agonists discriminate between individual G protein family subtypes.

Authors:  Marta Busnelli; Aude Saulière; Maurice Manning; Michel Bouvier; Celine Galés; Bice Chini
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  Evolutionary pattern in the OXT-OXTR system in primates: coevolution and positive selection footprints.

Authors:  Pedro Vargas-Pinilla; Vanessa Rodrigues Paixão-Côrtes; Pamela Paré; Luciana Tovo-Rodrigues; Carlos Meton de Alencar Gadelha Vieira; Agatha Xavier; David Comas; Alcides Pissinatti; Marialva Sinigaglia; Maurício Menegatti Rigo; Gustavo Fioravanti Vieira; Aldo B Lucion; Francisco Mauro Salzano; Maria Cátira Bortolini
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-22       Impact factor: 11.205

3.  By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization.

Authors:  Xavier Iturrioz; Romain Gerbier; Vincent Leroux; Rodrigo Alvear-Perez; Bernard Maigret; Catherine Llorens-Cortes
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

4.  Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.

Authors:  Laura Albizu; Martin Cottet; Michaela Kralikova; Stoytcho Stoev; René Seyer; Isabelle Brabet; Thomas Roux; Hervé Bazin; Emmanuel Bourrier; Laurent Lamarque; Christophe Breton; Marie-Laure Rives; Amy Newman; Jonathan Javitch; Eric Trinquet; Maurice Manning; Jean-Philippe Pin; Bernard Mouillac; Thierry Durroux
Journal:  Nat Chem Biol       Date:  2010-07-11       Impact factor: 15.040

Review 5.  Oxytocin and social motivation.

Authors:  Ilanit Gordon; Carina Martin; Ruth Feldman; James F Leckman
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

6.  Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats.

Authors:  Sara Sabihi; Nicole E Durosko; Shirley M Dong; Benedetta Leuner
Journal:  Psychoneuroendocrinology       Date:  2014-03-29       Impact factor: 4.905

Review 7.  Oxytocin as feeding inhibitor: maintaining homeostasis in consummatory behavior.

Authors:  Pawel K Olszewski; Anica Klockars; Helgi B Schiöth; Allen S Levine
Journal:  Pharmacol Biochem Behav       Date:  2010-06-02       Impact factor: 3.533

8.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

9.  A Comparison of the Ability of Leu8- and Pro8-Oxytocin to Regulate Intracellular Ca2+ and Ca2+-Activated K+ Channels at Human and Marmoset Oxytocin Receptors.

Authors:  Marsha L Pierce; Suneet Mehrotra; Aaryn C Mustoe; Jeffrey A French; Thomas F Murray
Journal:  Mol Pharmacol       Date:  2019-02-09       Impact factor: 4.436

Review 10.  Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

Authors:  S M Francis; A Sagar; T Levin-Decanini; W Liu; C S Carter; S Jacob
Journal:  Brain Res       Date:  2014-01-22       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.